In 2013, TIANGEN has occupied a leading position in China's nucleic acid Market (according to the authoritative third-party China market analysis report).
TIANGEN's virus extraction products, as raw materials, were recognized in the evaluation report on the emergency use of COVID-19 released by the World Health Organization in June 2020, and were listed in the recommended list of global new COVID-19 detection reagents released by the Global Fund in January 2021.
TIANGEN has provided more than 20 million tests of virus nucleic acid extraction reagent and 150 million tests of detection raw materials for COVID-19 prevention and detection.
TIANGEN has provided sample prep and detection kits to prevent the Africa Swine Fever in 30 provinces, and have detected 100 million pigs.
China Marrow Donor Program
TIANGEN has provided more than 1 million preps of blood DNA extraction for the China Marrow Donor Program.
TIANGEN has participated in developing Industry Standards with Ministry of Agriculture of China.
TIANGEN has provided more than 10 million preps of virus detection reagents for HFMD and Flu Monitoring.
TIANGEN has provided raw materials for HPV detection of more than 2.3 million samples.
Healthy Population Sample Library
TIANGEN has supplied the automated nucleic acid extraction solutions for the largest Healthy Population Sample Library in China.
Prenatal and Newborn Screening
TIANGEN has provided more than 3 million preps of medical sample detection kits for Prenatal and Newborn Screening.